Jennifer Jackson

Jennifer Jackson, PhD, has served as Senior Vice President, Global Regulatory Affairs and Quality Assurance since June 2015. Prior to joining TESARO, Dr. Jackson was Senior Vice President, Regulatory Affairs at Cubist Pharmaceuticals. She previously served as Vice President, Regulatory Affairs and Clinical Quality at Biogen Idec Hemophilia and before that was Vice President, Regulatory Affairs at Vertex Pharmaceuticals. She has more than 20 years of experience in global development and registration of small molecules and biologics in multiple therapeutic areas. Dr. Jackson received her doctoral degree in genetics from Cornell University, and her bachelors in biology from Reed College. She completed her post-doctoral training at the Massachusetts Institute of Technology.